NCT06344715 2024-04-03Phase 1 Study Evaluating Safety and Tolerability of SL-T10, GX-I7, and Pembrolizumab Triple Combination in mCRPC.SL VAXiGENPhase 1 Unknown78 enrolled
NCT05191784 2023-06-12GX-I7 in Combination With Bevacizumab in Recurrent Glioblastoma (GBM) PatientsGenexine, Inc.Phase 2 Unknown20 enrolled
NCT03206138 2017-07-02Safety and Efficacy of GX-188E Administered Via EP Plus GX-I7 or Imiquimod.Seoul St. Mary's HospitalPhase NA Unknown50 enrolled